The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Development Of A Rapid, Non-invasive And Biocompatible Bedside Sensing Method For Jaundice Embedded In A Newborn Nappy
Funder
National Health and Medical Research Council
Funding Amount
$541,744.00
Summary
Severe jaundice is a life threatening condition for which an effective screening tool in infants is currently unavailable. There is an urgent need to identify a suitable, reliable and affordable bedside test to positively impact upon the lives of millions of children worldwide by facilitating effective early intervention. This project will validate a non-invasive, affordable bedside test for neonatal jaundice, using a urine test positioned in a newborn’s nappy.
Development Of A First-in-class Therapeutic For Protecting The Ischemic Heart
Funder
National Health and Medical Research Council
Funding Amount
$926,673.00
Summary
Heart disease is the leading cause of death globally. Heart attacks are the primary cause of death associated with heart disease. We have discovered a drug, Hi1a, that blocks the injury response of the heart when a heart attack happens. There are no other drugs currently available or in the discovery pipeline that address this problem. This proposal will use models of injury to the heart as well as safety studies to help develop Hi1a as a new drug for people who suffer from heart attacks.